FOR IMMEDIATE RELEASE: Solulink Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody‐Labeling Technology

First Page		Document Content
Date: 2013-07-17 13:36:02 Immune system Clinical pathology Flow cytometry Antibody FluoProbes Biology Medicine Laboratory techniques		FOR IMMEDIATE RELEASE: Solulink Completes Equity Financing to Accelerate Commercialization and Licensing of HybriLink™ Antibody‐Labeling Technology Add to Reading List Source URL: www.solulink.com Download Document from Source Website File Size: 132,13 KB Share Document on Facebook